Screener
Neurocrine Biosciences NBIX Net product sales — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
| (in millions, except per share data) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Revenues: | ||
| Net product sales | $811.0 | $563.7 |
| Collaboration revenues | 3.5 | 8.9 |
| Total revenues | 814.5 | 572.6 |
| Operating expenses: | ||
| Cost of revenues | 13.8 | 9.2 |
| Research and development | 296.2 | 263.2 |
| Acquired in-process research and development | 21.2 | 0.1 |
Item 1. Financial Statements
FAQ
- What is Neurocrine Biosciences's net product sales — total revenues?
- Neurocrine Biosciences (NBIX) reported net product sales — total revenues of $811M in Q1 2026.
- How has Neurocrine Biosciences's net product sales — total revenues changed year-over-year?
- Neurocrine Biosciences's net product sales — total revenues increased by 43.9% year-over-year, from $563.7M to $811M.
- What is the long-term trend for Neurocrine Biosciences's net product sales — total revenues?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's net product sales — total revenues has grown at a 27.0% compound annual growth rate (CAGR), from $1.09B to $2.83B.
- What does net product sales — total revenues mean?
- This metric represents the total gross revenue generated from the sale of pharmaceutical products, net of allowances, rebates, and returns. It serves as the primary indicator of the commercial success and market adoption of the company's therapeutic portfolio. By isolating product-driven income, it allows investors to assess the core operational performance of the company's drug commercialization strategy.
Ask your AI about Neurocrine Biosciences's net product sales — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude